|
FR2828E
(fr)
|
1901-08-19 |
1904-06-30 |
Louis Emile Albert Durand |
Machine agricole dénommée gratteuse-bineuse-sulfateuse, destinée à travailler et sulfater simultanément les vignes ou tous végétaux plantés en rang
|
|
FR1275E
(fr)
|
1902-02-21 |
1903-07-01 |
Buil Francois Sebastien Joseph |
Système de fixation des poignées de vélocipèdes
|
|
FR2427E
(fr)
|
1903-08-19 |
1904-04-07 |
Paul Steinmetz |
Carburateur doseur, pour moteurs à explosion
|
|
FR5528E
(fr)
|
1905-03-16 |
1906-05-02 |
Farcot Freres Et Cie Soc |
Perfectionnements aux turbines à vapeur ou à gaz
|
|
DE1118403B
(de)
|
1960-01-27 |
1961-11-30 |
Hoechst Ag |
Verfahren zur Gewinnung von antitumorwirksamen Sporen
|
|
FR1275M
(fr)
|
1961-05-06 |
1962-05-02 |
Rene Roger |
Médicament a base de colibacilles vivants.
|
|
NL294835A
(enExample)
|
1962-07-19 |
1900-01-01 |
|
|
|
FR2828M
(fr)
|
1963-03-01 |
1964-11-02 |
Lucien Nouvel |
Médicament renfermant des colibacilles antibiorésistants.
|
|
FR5528M
(enExample)
|
1965-10-01 |
1967-11-13 |
|
|
|
GB1271674A
(en)
|
1968-07-09 |
1972-04-26 |
Nisshin Flour Milling Co |
Process and preparation for treating diarrhoea in pigs
|
|
SE371209B
(enExample)
|
1969-10-13 |
1974-11-11 |
Cernelle Ab |
|
|
DE2134179A1
(de)
|
1971-07-09 |
1973-01-25 |
Rolf Dr Schuler |
Bifidobakterien enthaltendes praeparat und verfahren zur herstellung desselben
|
|
FR2244464A1
(en)
|
1973-06-26 |
1975-04-18 |
Serozym Laboratoires |
Yeast, lacto- and colibacillus based compsns - used to modify intestinal flora, treat colitis and digestive disorders, etc.
|
|
US4098728A
(en)
|
1976-01-02 |
1978-07-04 |
Solomon Rosenblatt |
Medical surgical sponge and method of making same
|
|
US4335107A
(en)
|
1978-06-05 |
1982-06-15 |
Snoeyenbos Glenn H |
Mixture to protect poultry from salmonella
|
|
CH637297A5
(fr)
|
1978-12-05 |
1983-07-29 |
Nestle Sa |
Microbille comprenant un microorganisme et son procede de fabrication.
|
|
US4309782A
(en)
|
1980-09-11 |
1982-01-12 |
Esteban Paulin |
Device for collecting fecal specimens
|
|
US4536409A
(en)
|
1981-01-23 |
1985-08-20 |
American Can Company |
Oxygen scavenger
|
|
US4394377A
(en)
|
1981-07-31 |
1983-07-19 |
Syntex (U.S.A.) Inc. |
Ruminant animal performance by co-administering choline and propionate enchancers
|
|
US4452779A
(en)
|
1982-02-03 |
1984-06-05 |
Cockerill Vernon |
Composition and method of treating lactating mammals
|
|
FI840816A0
(fi)
|
1984-03-01 |
1984-03-01 |
Farmos Oy |
Bakteriepreparat
|
|
JPS615022A
(ja)
|
1984-06-19 |
1986-01-10 |
Advance Res & Dev Co Ltd |
腸内細菌叢改善剤
|
|
US4892731A
(en)
|
1986-12-11 |
1990-01-09 |
Tadashi Arai |
Biological intestinal antiseptics
|
|
IL86859A
(en)
|
1987-07-10 |
1991-12-15 |
E Z Em Inc |
Aqueous cathartic solution containing inorganic salts
|
|
US4948734A
(en)
|
1987-08-12 |
1990-08-14 |
Mycogen Corporation |
Novel isolates of bacillus thuringiensis having activity against nematodes
|
|
EP0433299B1
(en)
|
1988-08-02 |
1998-05-06 |
Gastro Services Pty. Limited (ACN 002 994 890) |
Treatment of gastro-intestinal disorders
|
|
US5443826A
(en)
|
1988-08-02 |
1995-08-22 |
Borody; Thomas J. |
Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
|
|
US5213807A
(en)
|
1990-05-03 |
1993-05-25 |
Chemburkar Pramod B |
Pharmaceutical composition containing ibuprofen and a prostaglandin
|
|
US5266315A
(en)
|
1990-05-07 |
1993-11-30 |
Kabushiki Kaisha Miyarisan Seibutsu Igaku Kenkyusho |
Composite for Clostridium difficile diarrhea and pseudomembranous colitis
|
|
JP2961184B2
(ja)
|
1990-05-07 |
1999-10-12 |
ミヤリサン株式会社 |
クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物
|
|
GB9107305D0
(en)
|
1991-04-08 |
1991-05-22 |
Unilever Plc |
Probiotic
|
|
JP3047143B2
(ja)
|
1992-04-24 |
2000-05-29 |
堀井薬品工業株式会社 |
腸管洗浄液用組成物及び腸管洗浄液
|
|
JP3850891B2
(ja)
|
1994-03-01 |
2006-11-29 |
ゼリア新薬工業株式会社 |
緩下効果を有する組成物
|
|
US6984513B2
(en)
|
1994-03-03 |
2006-01-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Anaerobe targeted enzyme-mediated prodrug therapy
|
|
JPH07242557A
(ja)
|
1994-03-03 |
1995-09-19 |
Ss Pharmaceut Co Ltd |
乳酸菌含有瀉下薬組成物
|
|
WO1995033046A1
(en)
|
1994-05-26 |
1995-12-07 |
Bracco S.P.A. |
Lactobacillus strains of human origin, their compositions and uses thereof
|
|
US5599795A
(en)
|
1994-08-19 |
1997-02-04 |
Mccann; Michael |
Method for treatment of idiopathic inflammatory bowel disease (IIBD)
|
|
AUPM864894A0
(en)
|
1994-10-07 |
1994-11-03 |
Borody, Thomas Julius |
Treatment of bowel-dependent neurological disorders
|
|
US5800821A
(en)
|
1995-03-10 |
1998-09-01 |
New England Medical Center Hospitals, Inc. |
Bacterial spores as a heat stable vaccine delivery system
|
|
US7048906B2
(en)
|
1995-05-17 |
2006-05-23 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
|
|
US5858356A
(en)
|
1995-12-21 |
1999-01-12 |
Abbott Laboratories |
Lactobacillus acidophilus to inhibit cryptosporidiosis in mammals
|
|
US5902578A
(en)
|
1996-03-25 |
1999-05-11 |
Abbott Laboratories |
Method and formula for the prevention of diarrhea
|
|
US5837238A
(en)
|
1996-06-05 |
1998-11-17 |
Biogaia Biologics Ab |
Treatment of diarrhea
|
|
US6087386A
(en)
|
1996-06-24 |
2000-07-11 |
Merck & Co., Inc. |
Composition of enalapril and losartan
|
|
WO1998013068A1
(fr)
|
1996-09-26 |
1998-04-02 |
Vladimir Borisovich Kuperman |
Medicament prophylactique 'trisan'
|
|
US5948787A
(en)
|
1997-02-28 |
1999-09-07 |
Alza Corporation |
Compositions containing opiate analgesics
|
|
US6162464A
(en)
|
1997-03-31 |
2000-12-19 |
Inkine Pharmaceutical, Inc. |
Non-aqueous colonic purgative formulations
|
|
US7374753B1
(en)
|
1997-06-03 |
2008-05-20 |
Ganeden Biotech, Inc. |
Probiotic lactic acid bacterium to treat bacterial infections associated with SIDS
|
|
US6428783B1
(en)
|
1998-03-11 |
2002-08-06 |
Medtech Center, Inc. |
Bank of autochthonous strains of microorganisms and methods of its use for recovery of intestinal microbiocenosis of the men
|
|
US5902743A
(en)
|
1998-03-20 |
1999-05-11 |
Wisconsin Alumni Research Foundation |
Probiotic bifidobacterium strain
|
|
EP1077252A1
(en)
|
1998-05-06 |
2001-02-21 |
Keijiro Nakamura |
Microbial culture liquors containing microorganisms differing in characteristics and living in symbiosis and metabolites thereof, carriers and adsorbents containing the active components of the culture liquors and utilization of the same
|
|
US6368591B2
(en)
|
1998-05-15 |
2002-04-09 |
Shanghai Sine Pharmaceutical Corporation Ltd. |
Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof
|
|
AT407008B
(de)
|
1998-08-06 |
2000-11-27 |
Viernstein Helmut Dr |
Formulierungen mit probiotisch wirksamen mikroorganismen
|
|
US6461607B1
(en)
|
1998-08-24 |
2002-10-08 |
Ganeden Biotech, Inc. |
Probiotic, lactic acid-producing bacteria and uses thereof
|
|
HUP0103502A2
(hu)
|
1998-09-17 |
2002-01-28 |
Baxter Healthcare S.A. |
Streptococcus Cbéta-fehérje készítmények
|
|
EP1005863A1
(en)
|
1998-12-04 |
2000-06-07 |
Synthelabo |
Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
|
|
WO2000035465A2
(en)
|
1998-12-11 |
2000-06-22 |
Urex Biotech Inc. |
Oral administration of lactobacillus for the treatment and prevention of urogenital infection
|
|
US6245740B1
(en)
|
1998-12-23 |
2001-06-12 |
Amgen Inc. |
Polyol:oil suspensions for the sustained release of proteins
|
|
ID29150A
(id)
|
1999-01-15 |
2001-08-02 |
Entpr Ireland Cs |
Penggunaan lactobacillus salivarius
|
|
ATE407666T1
(de)
|
1999-02-26 |
2008-09-15 |
Shionogi & Co |
Kaubare weichkapseln mit verbesserten verabreichungseigenschaften sowie verfahren zu deren herstellung
|
|
FR2808689B1
(fr)
|
2000-05-11 |
2004-09-03 |
Agronomique Inst Nat Rech |
Utilisation de souches acetogenes hydrogenotrophes pour la prevention ou le traitement de troubles digestifs
|
|
US20040062757A1
(en)
|
2001-06-05 |
2004-04-01 |
Finegold Sydney M. |
Method of testing gastrointestinal diseases associated with species of genus clostridium
|
|
US20040170617A1
(en)
|
2000-06-05 |
2004-09-02 |
Finegold Sydney M. |
Method of treating diseases associated with abnormal gastrointestinal flora
|
|
US20020013270A1
(en)
|
2000-06-05 |
2002-01-31 |
Bolte Ellen R. |
Method for treating a mental disorder
|
|
US6756032B1
(en)
|
2000-07-12 |
2004-06-29 |
The Procter & Gamble Company |
Method to enhance and/or prolong the effects of a primary challenge to a responsive system with a secondary challenge
|
|
CA2416120A1
(en)
|
2000-07-17 |
2002-01-24 |
Svend Laulund |
Methods and formulations with probiotic microorganisms and medicaments
|
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
|
US7214370B2
(en)
|
2000-12-18 |
2007-05-08 |
Probiohealth, Llc |
Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
|
|
US6790453B2
(en)
|
2001-03-14 |
2004-09-14 |
Mccormick & Company, Inc. |
Encapsulation compositions and process for preparing the same
|
|
US7815956B2
(en)
|
2001-04-27 |
2010-10-19 |
Pepsico |
Use of erythritol and D-tagatose in diet or reduced-calorie beverages and food products
|
|
AU2002305758B2
(en)
|
2001-06-01 |
2006-09-07 |
Nuvo Pharmaceuticals (Ireland) Designated Activity Company |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
|
EP1410794A1
(en)
|
2001-07-05 |
2004-04-21 |
Wakunaga Pharmaceutical Co., Ltd. |
Soft capsules
|
|
PE20030284A1
(es)
|
2001-07-26 |
2003-05-01 |
Alimentary Health Ltd |
Cepas de bifidobacterium
|
|
US20030092724A1
(en)
|
2001-09-18 |
2003-05-15 |
Huaihung Kao |
Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic
|
|
GB0124580D0
(en)
|
2001-10-12 |
2001-12-05 |
Univ Reading |
New composition
|
|
DE60325567D1
(de)
|
2002-04-05 |
2009-02-12 |
Euro Celtique Sa |
Matrix für die modifizierte freigabe von aktiven substanzen
|
|
CA2391422A1
(en)
|
2002-07-12 |
2004-01-12 |
David William Molloy |
Rifampin (rifadin, rimactone, rifampicin) and doxycycline, (doryx, vibramycin) and the tetracyclines and other compounds currently classified as antibiotics and anti-tuberculous drugs as a treatment to prevent, modify disease progression and/or improve symptoms for neurodegenerative diseases including alzheimers disease, lewy body dementia, schizophrenia,...
|
|
IL152127A0
(en)
|
2002-10-06 |
2003-05-29 |
Bio Balance Corp |
Probiotic compositions for the treatment of inflammatory bowel disease
|
|
RU2006108554A
(ru)
|
2003-08-18 |
2007-09-27 |
Дзе Байо Бэлэнс Корпорейшн (Us) |
Устойчивая жидкая пробиотическая композиция, ее получение и применения
|
|
US7759105B2
(en)
|
2003-08-29 |
2010-07-20 |
Cobb & Company, Llp |
Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
|
|
US8192733B2
(en)
|
2003-08-29 |
2012-06-05 |
Cobb & Associates |
Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
|
|
US20060177424A1
(en)
|
2003-08-29 |
2006-08-10 |
Cobb Mark L |
Treatment of disease states and adverse physiological conditions utilizing anti-fungal compositions
|
|
US7749509B2
(en)
|
2003-08-29 |
2010-07-06 |
Cobb And Company, Llp |
Treatment of autism using probiotic composition
|
|
US8016816B2
(en)
|
2003-09-09 |
2011-09-13 |
Convatec Technologies Inc. |
Fecal management appliance and method and apparatus for introducing same
|
|
US7541091B2
(en)
|
2004-05-18 |
2009-06-02 |
M & G Usa Corporation |
Compartmentalized resin pellets for oxygen scavenging
|
|
PL1673100T3
(pl)
|
2004-08-05 |
2008-01-31 |
Anidral Srl |
Szczepy bakterii Bifidobacterium wytwarzające kwas foliowy, preparaty i ich zastosowanie
|
|
ATE367821T1
(de)
|
2004-08-05 |
2007-08-15 |
Anidral Srl |
Folsäure produzierende bifidobacterium bakterienstämme, ihre formulierungen und verwendung
|
|
US20060076536A1
(en)
|
2004-09-29 |
2006-04-13 |
Barshied Scott R |
Oxygen scavenging pharmaceutical package and methods for making same
|
|
US20060115465A1
(en)
|
2004-10-29 |
2006-06-01 |
Macfarlane George |
Treatment of gastrointestinal disorders
|
|
CN101217945B
(zh)
|
2005-05-20 |
2012-07-11 |
陶氏环球技术有限责任公司 |
使用射频识别标签的口服用药依从性监视
|
|
US20060275223A1
(en)
|
2005-06-02 |
2006-12-07 |
Burr James B |
Erythritol compositions for teeth and gums
|
|
TWI362949B
(en)
|
2005-09-13 |
2012-05-01 |
Bion Tech Inc |
Intestines dissolving nature is able to bear the hydrochloric acid in gastric juice and wrap up the benefit covered and grow the fungus of makes up
|
|
CA2635313C
(en)
|
2005-12-29 |
2013-12-31 |
Osmotica Corp. |
Triple combination release multi-layered tablet
|
|
JP5006567B2
(ja)
|
2006-04-14 |
2012-08-22 |
花王株式会社 |
口腔用固形製剤
|
|
US7998510B2
(en)
|
2006-08-17 |
2011-08-16 |
C. B. Fleet Company, Inc. |
Low dose colonic cleansing system
|
|
JP2008106066A
(ja)
|
2006-09-25 |
2008-05-08 |
Tashiro Yasuaki |
サポニン及び生菌を含有する組成物
|
|
DE102006062250A1
(de)
|
2006-12-22 |
2008-06-26 |
Roland Saur-Brosch |
Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden
|
|
US8586026B2
(en)
|
2007-03-01 |
2013-11-19 |
Probi Ab |
Bacterial diversity
|
|
US8557233B2
(en)
|
2007-03-28 |
2013-10-15 |
Alimentary Heath Limited |
Probiotic bifidobacterium strains
|
|
WO2008117267A2
(en)
|
2007-03-28 |
2008-10-02 |
Alimentary Health Limited |
Probiotic bifidobacterium strains
|
|
EP2155167A2
(en)
|
2007-06-04 |
2010-02-24 |
Egalet A/S |
Controlled release pharmaceutical compositions for prolonged effect
|
|
US20100184785A1
(en)
|
2007-06-06 |
2010-07-22 |
Basf Se |
Pharmaceutical formulation for the production of chewable tablets and lozenges
|
|
US10406105B2
(en)
|
2007-06-06 |
2019-09-10 |
Basf Se |
Pharmaceutical formulation for the production of rapidly disintegrating tablets
|
|
BRPI0814175A2
(pt)
|
2007-07-27 |
2015-01-20 |
Cargill Inc |
Micronização de polióis
|
|
EP2030623A1
(en)
|
2007-08-17 |
2009-03-04 |
Nestec S.A. |
Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
|
|
ATE548423T1
(de)
|
2007-08-31 |
2012-03-15 |
Invista Tech Sarl |
Sauerstoffabsorbierende kunststoffzusammensetzungen
|
|
EP2196221A4
(en)
|
2007-09-27 |
2011-12-28 |
Mitsubishi Tanabe Pharma Corp |
QUICKLY CRUMPING SOLID PREPARATION
|
|
JP2010540588A
(ja)
|
2007-10-01 |
2010-12-24 |
ラボラトリオス、レスビ、ソシエダッド、リミターダ |
口腔内崩壊錠剤
|
|
CN101896161A
(zh)
|
2007-10-19 |
2010-11-24 |
普渡（大学）研究基金 |
结晶化合物的固体制剂
|
|
WO2009049932A1
(en)
|
2007-10-20 |
2009-04-23 |
Universite De Liege |
Bifidobacterial species
|
|
EP2211879B1
(en)
|
2007-10-26 |
2014-05-07 |
Brenda E. Moore |
Probiotic compositions and methods for inducing and supporting weight loss
|
|
JP5258268B2
(ja)
|
2007-11-19 |
2013-08-07 |
フロイント産業株式会社 |
球形粒の製造方法
|
|
WO2009084678A1
(ja)
|
2007-12-28 |
2009-07-09 |
Sawai Pharmaceutical Co., Ltd. |
口腔内崩壊錠およびその製造方法
|
|
EP2350096B1
(en)
|
2008-10-02 |
2019-12-11 |
Salix Pharmaceuticals, Ltd. |
Methods of treating hepatic encephalopathy
|
|
US20100178413A1
(en)
|
2008-12-17 |
2010-07-15 |
Mark Gorris |
Food-based Supplement Delivery System
|
|
WO2010103132A1
(es)
|
2009-03-10 |
2010-09-16 |
Hero España, S.A. |
Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
|
|
US20100255231A1
(en)
|
2009-04-01 |
2010-10-07 |
Multisorb Technologies, Inc. |
Oxygen scavenging films
|
|
WO2010124855A1
(en)
|
2009-04-30 |
2010-11-04 |
Actogenix Nv |
Cryoprotectants for freeze drying of lactic acid bacteria
|
|
US20100285164A1
(en)
|
2009-05-11 |
2010-11-11 |
Jrs Pharma |
Orally Disintegrating Excipient
|
|
WO2010138439A1
(en)
|
2009-05-28 |
2010-12-02 |
Aptapharma, Inc. |
Multiparticulate controlled-release selective serotonin reuptake inhibitor formulations
|
|
CN201441672U
(zh)
|
2009-07-14 |
2010-04-28 |
赵伟华 |
一次性灌肠装置
|
|
US20110045222A1
(en)
|
2009-08-19 |
2011-02-24 |
Eastman Chemical Company |
Oxygen-scavenging polymer blends suitable for use in packaging
|
|
GB0916335D0
(en)
|
2009-09-17 |
2009-10-28 |
Martin W J |
Medicaments
|
|
US20110081320A1
(en)
|
2009-10-06 |
2011-04-07 |
Nubiome, Inc. |
Treatment/Cure of Autoimmune Disease
|
|
US20120276149A1
(en)
|
2009-10-15 |
2012-11-01 |
Dan Littman |
Methods for modulating bacterial infection
|
|
US20110218216A1
(en)
|
2010-01-29 |
2011-09-08 |
Kumaravel Vivek |
Extended release pharmaceutical composition of donepezil
|
|
US7888062B1
(en)
|
2010-02-01 |
2011-02-15 |
Microbios, Inc. |
Process and composition for the manufacture of a microbial-based product
|
|
ES2730828T3
(es)
|
2010-02-01 |
2019-11-12 |
Rebiotix Inc |
Bacterioterapia para la colitis por Clostridium difficile
|
|
US8853269B2
(en)
|
2010-02-04 |
2014-10-07 |
Copperhead Chemical Company Inc. |
Composition and method for treating infections and promoting intestinal health
|
|
AU2011226324B2
(en)
|
2010-03-10 |
2015-09-24 |
Nogra Pharma Limited |
Compositions for colon lavage and methods of making and using same
|
|
US9707207B2
(en)
|
2010-05-26 |
2017-07-18 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Method for diagnosing, preventing, and treating neurological diseases
|
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
|
|
NZ618935A
(en)
|
2010-08-04 |
2014-03-28 |
Karma Medical Prod Co Ltd |
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
|
|
WO2012045150A1
(en)
|
2010-10-04 |
2012-04-12 |
British Columbia Cancer Agency Branch |
Detection of fusobacterium in a gastrointestinal sample to diagnose gastrointestinal cancer
|
|
US9452189B2
(en)
|
2010-10-07 |
2016-09-27 |
California Institute Of Technology |
Probiotic therapies for autism
|
|
WO2014152484A1
(en)
*
|
2013-03-14 |
2014-09-25 |
Regents Of The University Of Minnesota |
Freeze dried fecal microbiota for use in fecal microbial transplantation
|
|
US20150374761A1
(en)
|
2011-03-09 |
2015-12-31 |
Regents Of The University Of Minnesota |
Freeze dried fecal microbiota for use in fecal microbial transplantation
|
|
WO2012122478A1
(en)
|
2011-03-09 |
2012-09-13 |
Regents Of The University Of Minnesota |
Compositions and methods for transplantation of colon microbiota
|
|
EP2744890A4
(en)
|
2011-09-14 |
2015-07-08 |
Univ Kingston |
METHOD FOR TREATING DISORDERS OF THE MAGENDAR SYSTEM
|
|
PL2750682T3
(pl)
|
2011-10-11 |
2016-10-31 |
|
Kompozycja zawierająca hodowaną beztlenowo ludzką mikroflorę jelitową
|
|
EP4477750A3
(en)
|
2011-12-01 |
2025-03-26 |
The University of Tokyo |
Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
|
|
US9176026B2
(en)
|
2011-12-15 |
2015-11-03 |
Pureflora, Inc. |
Device for the collection, refinement, and administration of gastrointestinal microflora
|
|
WO2013166336A1
(en)
|
2012-05-02 |
2013-11-07 |
Charles River Laboratories, Inc. |
Viability staining method
|
|
US9719144B2
(en)
|
2012-05-25 |
2017-08-01 |
Arizona Board Of Regents |
Microbiome markers and therapies for autism spectrum disorders
|
|
US10220089B2
(en)
|
2012-08-29 |
2019-03-05 |
California Institute Of Technology |
Diagnosis and treatment of autism spectrum disorder
|
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
|
US20150297642A1
(en)
|
2012-11-26 |
2015-10-22 |
Thomas Julius Borody |
Compositions for the restoration of a fecal microbiota and methods for making and using them
|
|
JP2016509003A
(ja)
|
2013-02-04 |
2016-03-24 |
セレス セラピューティクス インコーポレイテッド |
組成物および方法
|
|
RU2015140610A
(ru)
|
2013-03-14 |
2017-04-17 |
ТЕРАБАЙОМ, ЭлЭлСи |
Направленная доставка в желудочно-кишечный тракт пробиотических микроорганизмов и/или терапевтических средств
|
|
AU2014262125B2
(en)
|
2013-04-30 |
2020-02-13 |
Thomas Julius Borody |
Compositions and methods for treating microbiota-related psychotropic conditions and diseases
|
|
US9511100B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
|
US9511099B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
|
US9675648B2
(en)
|
2013-06-05 |
2017-06-13 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
|
US9782445B2
(en)
|
2013-06-05 |
2017-10-10 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
|
WO2015006355A2
(en)
|
2013-07-09 |
2015-01-15 |
Puretech Ventures, Llc |
Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease
|
|
CA2926466C
(en)
|
2013-10-03 |
2021-11-16 |
Frederic Bushman |
Compositions comprising a defined microbiome and methods of use thereof
|
|
EP3074027B1
(en)
|
2013-11-25 |
2024-12-18 |
Seres Therapeutics, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
|
US9956282B2
(en)
|
2013-12-16 |
2018-05-01 |
Seres Therapeutics, Inc. |
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
|
BR112017024264B1
(pt)
|
2015-05-14 |
2022-07-12 |
Crestovo Holdings Llc |
Composições para transplante de flora fecal e métodos de preparação e utilização das mesmas, e dispositivos para sua administração
|
|
HUE058209T2
(hu)
|
2015-05-22 |
2022-07-28 |
Univ Arizona State |
Módszerek az autizmus spektrum zavar és azzal összefüggõ tünetek kezelésére
|
|
JP2018535254A
(ja)
|
2015-10-26 |
2018-11-29 |
クレストヴォ・ホールディングス・エルエルシー |
便微生物叢関連療法のための組成物及び方法
|
|
JP7327773B2
(ja)
|
2016-03-04 |
2023-08-16 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
微生物共同体およびその使用
|
|
US20180036352A1
(en)
*
|
2016-08-03 |
2018-02-08 |
Crestovo Holdings Llc |
Methods for treating ulcerative colitis
|